Newswire (Published: Tuesday, March 14, 2017, 12:01:00 AM CDT, Received: Friday, March 10, 2017, 4:07:14 AM CST)

Word Count: 465

Findings from University of Michigan Update Understanding of Prostate Cancer [ACR Appropriateness Criteria ® Locally Advanced, High-Risk Prostate Cancer]

By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Oncology - Prostate Cancer have been presented. According to news reporting originating in Novi, Michigan, by NewsRx journalists, research stated, "To present the most updated American College of Radiology consensus guidelines formed from an expert panel on treatment of locally advanced, high-risk prostate cancer Methods: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios."

The news reporters obtained a quote from the research from the University of Michigan, "In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment. The panel summarized the most recent and relevant literature on the topic and voted on 4 clinical variants illustrating the appropriate management of locally advanced, high-risk cancer. Numerical rating and commentary reflecting the panel consensus was given for each treatment approach in each variant. Aggressive local approaches including surgery followed by adjuvant XRT, beam combined with androgen deprivation therapy, and beam combined with brachytherapy have resulted in unpresented success in locally advanced, high-risk prostate cancer."

According to the news reporters, the research concluded: "By combining most recent medical literature and expert opinion, this guideline can aid clinicians in the appropriate integration of available therapeutic modalities."

For more information on this research see: ACR Appropriateness Criteria ® Locally Advanced, High-Risk Prostate Cancer. American Journal of Clinical Oncology-Cancer Clinical Trials, 2017;40(1):1-10. American Journal of Clinical Oncology-Cancer Clinical Trials can be contacted at: Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA (see also Oncology - Prostate Cancer).

Our news correspondents report that additional information may be obtained by contacting P.W. McLaughlin, University of Michigan, Novi, MI, United States. Additional authors for this research include A.L. Liss, P.L. Nguyen, D.G. Assimas, A.V. D'Amico, A.R. Gottschalk, G.S. Gustafson, S.R. Keol, S.L. Liauw, S. Lloyd, B. Movsas, B.R. Prestidg, T.N. Showalter, A.V. Taira, N. Vapiwal and B.J. Davi.

Keywords for this news article include: Novi, Michigan, United States, North and Central America, Prostatic Neoplasms, Prostate Cancer, Oncology, University of Michigan.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC


American College of Radiology Inc
University of Michigan
Lippincott Williams & Wilkins
Wolters Kluwer N.V.
Wolters Kluwer N.V.
Wolters Kluwer N.V.


Central America
North America
United States


Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Medical Specialties and Practices